Vigil neuroscience investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of vigil neuroscience, inc. - vigl

New york & new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of vigil neuroscience, inc. (nasdaqgs: vigl) to sanofi (nasdaqgs: sny). under the terms of the proposed transaction, shareholders of vigil will receive $8.00 in cash for each share of vigil that they own as well as a non-tradeable contingent value right entitling the holder to potentially receive an ad.
GM Ratings Summary
GM Quant Ranking